Michihiro Maeda
Commentary on Protein-Protein and Protein-Peptide Interactions, peptidomimetics and related topics in drug discovery.

Michihiro Maeda

Michihiro Maeda joined PRISM BioLab as CFO / Corporate Director. After obtaining an Economics degree at Austin College, TX, he took on various Finance responsibilities including M&A / IR / operational turnaround at USEN, CFO at Abbott Japan and Finance lead at Aillis Inc., as well as IPO / Fund raising lead at Promethera Biosciences Japan branch. He also comes with profound general management experiences as general manager and business expansion lead at both large corporations and small startup settings.

Scroll to top